Medtronic plc (SA:MDTC34) — Stock Price
Medtronic plc (SA:MDTC34) is currently trading at R$208.39 BRL, down 5.09% today. Over the past 52 weeks, shares have ranged between R$208.39 and R$276.64. This page tracks Medtronic plc's live share price on the SA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see MDTC34 market cap overview.
Medtronic plc (MDTC34) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Medtronic plc's daily closing share price and trading volume on the SA exchange over the past year, giving a clear view of recent price momentum and liquidity.
Medtronic plc Income Statement — Revenue, Profit & Earnings by Year
Medtronic plc's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | R$36.36 Billion | R$33.54 Billion | R$32.36 Billion | R$31.23 Billion | R$31.69 Billion |
| Cost of Revenue | R$12.72 Billion | R$11.61 Billion | R$11.09 Billion | R$10.62 Billion | R$10.14 Billion |
| Gross Profit | R$23.64 Billion | R$21.93 Billion | R$21.27 Billion | R$20.61 Billion | R$21.54 Billion |
| Research & Development | R$2.87 Billion | R$2.73 Billion | R$2.73 Billion | R$2.70 Billion | R$2.75 Billion |
| SG&A | R$11.78 Billion | R$10.84 Billion | R$10.63 Billion | R$10.24 Billion | R$10.29 Billion |
| Total Operating Expenses | R$29.54 Billion | R$27.58 Billion | R$27.22 Billion | R$25.80 Billion | R$25.78 Billion |
| Operating Income | R$6.83 Billion | R$5.96 Billion | R$5.14 Billion | R$5.43 Billion | R$5.91 Billion |
| EBITDA | — | — | — | — | R$8.78 Billion |
| EBIT | — | — | — | — | R$7.02 Billion |
| Interest Expense | R$715.00 Million | R$729.00 Million | R$719.00 Million | R$636.00 Million | R$553.00 Million |
| Income Before Tax | R$6.14 Billion | R$5.63 Billion | R$4.84 Billion | R$5.36 Billion | R$5.52 Billion |
| Income Tax Expense | — | — | — | — | R$456.00 Million |
| Net Income | R$4.80 Billion | R$4.66 Billion | R$3.68 Billion | R$3.76 Billion | R$5.04 Billion |
Medtronic plc Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Medtronic plc's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | R$93.03 Billion | R$91.68 Billion | R$89.98 Billion | R$90.95 Billion | R$90.98 Billion |
| Total Current Assets | R$24.79 Billion | R$23.81 Billion | R$21.93 Billion | R$21.68 Billion | R$23.06 Billion |
| Cash & Equivalents | — | R$2.22 Billion | R$1.28 Billion | R$1.54 Billion | R$3.71 Billion |
| Short-term Investments | R$7.27 Billion | R$6.75 Billion | R$6.72 Billion | R$6.42 Billion | R$6.86 Billion |
| Net Receivables | R$6.64 Billion | R$6.51 Billion | R$6.13 Billion | R$6.00 Billion | R$5.55 Billion |
| Inventory | R$5.95 Billion | R$5.48 Billion | R$5.22 Billion | R$5.29 Billion | R$4.62 Billion |
| Property, Plant & Equipment | — | R$7.94 Billion | R$7.14 Billion | R$6.61 Billion | R$6.27 Billion |
| Goodwill | R$42.59 Billion | R$41.74 Billion | R$40.99 Billion | R$41.42 Billion | R$40.50 Billion |
| Total Liabilities | R$42.96 Billion | R$43.42 Billion | R$39.77 Billion | R$39.47 Billion | R$38.26 Billion |
| Total Current Liabilities | R$11.66 Billion | R$12.88 Billion | R$10.79 Billion | R$9.05 Billion | R$12.39 Billion |
| Long-term Debt | R$26.12 Billion | R$25.59 Billion | R$23.88 Billion | R$24.29 Billion | R$20.32 Billion |
| Net Debt | R$25.95 Billion | R$26.24 Billion | R$23.68 Billion | R$22.76 Billion | R$20.34 Billion |
| Total Stockholder Equity | R$49.46 Billion | R$48.02 Billion | R$50.21 Billion | R$51.48 Billion | R$52.55 Billion |
| Retained Earnings | R$32.64 Billion | R$31.48 Billion | R$30.40 Billion | R$30.39 Billion | R$30.25 Billion |
Medtronic plc Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Medtronic plc generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | R$7.33 Billion | R$7.04 Billion | R$6.79 Billion | R$6.04 Billion | R$7.35 Billion |
| Capital Expenditures | R$1.90 Billion | R$1.86 Billion | R$1.59 Billion | R$1.46 Billion | R$1.37 Billion |
| Free Cash Flow | R$5.43 Billion | R$5.18 Billion | R$5.20 Billion | R$4.58 Billion | R$5.98 Billion |
| Investing Cash Flow | — | R$-1.94 Billion | R$-2.37 Billion | R$-3.49 Billion | R$-1.66 Billion |
| Financing Cash Flow | R$-4.75 Billion | R$-4.36 Billion | R$-4.45 Billion | R$-4.96 Billion | R$-5.34 Billion |
| Dividends Paid | R$-3.64 Billion | R$3.59 Billion | R$3.67 Billion | R$3.62 Billion | R$3.38 Billion |
| Stock-Based Compensation | R$457.00 Million | R$429.00 Million | R$393.00 Million | R$355.00 Million | R$359.00 Million |
| Depreciation | R$2.96 Billion | R$2.86 Billion | R$2.65 Billion | R$2.70 Billion | R$2.71 Billion |
| Change in Cash | R$-269.00 Million | R$934.00 Million | R$-259.00 Million | R$-2.17 Billion | R$121.00 Million |
Medtronic plc Earnings History — EPS Actual vs. Analyst Estimates
Track Medtronic plc's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 20, 2026 | — | — | — |
| Feb 17, 2026 | — | — | — |
| Nov 18, 2025 | — | — | — |
| Aug 19, 2025 | — | — | — |
| May 21, 2025 | — | — | — |